Chemical Component Summary

Name5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid
Identifiers5-(2,5-dimethylphenoxy)-2,2-dimethyl-pentanoic acid
FormulaC15 H22 O3
Molecular Weight250.33
Isomeric SMILESCc1ccc(c(c1)OCCCC(C)(C)C(=O)O)C

Chemical Details

Formal Charge0
Atom Count40
Chiral Atom Count0
Bond Count40
Aromatic Bond Count6

Drug Info: DrugBank

DrugBank IDDB01241 
DescriptionGemfibrozil is a fibric acid agent, similar to [clofibrate], used to treat Type IIb, IV, and V hyperlipidemias.[A185777,L8525] Gemfibrozil is not a first line treatment and is prescribed to patients who have not responded adequately to weight loss, diet, exercise, and other medications.[L8525] Gemfibrozil was granted FDA approval on 21 December 1981.[L8525]
  • 2,2-Dimethyl-5-(2,5-xylyloxy)valeriansäure
  • Gemfibrozilo
  • Gemfibrozilum
  • 2,2-Dimethyl-5-(2,5-dimethylphenoxy)valeriansäure
  • Gemfibrozil
Brand Names
  • Apo-gemfibrozil Cap 300mg USP
  • Dom-gemfibrozil
  • Lopid 600mg
  • Gemfibrozil Cap 300mg
  • Lopid
IndicationGemfibrozil is indicated to treat patients with Types IV and V hyperlipidemia who have elevated serum triglycerides (usually above 2000mg/dL), elevated VLDL cholesterol, fasting chylomicrons, are at risk of developing pancreatitis, and do not adequately respond to dietary restrictions.[L8525] Gemfibrozil is also indicated to reduce the risk of developing coronary heart disease in patients with Type IIb hyperlipidemia without history or symptoms of coronary heart disease; who do not adequately respond to weight loss, diet, exercise, and other medications; and have low HDL, raised LDL, and raised triglycerides.[L8525]
  • Acids, Acyclic
  • Agents Causing Muscle Toxicity
  • Benzene Derivatives
  • Butyrates
  • Chemically-Induced Disorders
CAS number25812-30-0

Drug Targets

NameTarget SequencePharmacological ActionActions
Peroxisome proliferator-activated receptor alphaMVDTESPLCPLSPLEAGDLESPLSEEFLQEMGNIQEISQSIGEDSSGSFG...unknownagonist
Solute carrier organic anion transporter family member 1B1MDQNQHLNKTAEAQPSENKKTRYCNGLKMFLAALSLSFIAKTLGAIIMKS...unknowninhibitor
Solute carrier family 22 member 8MTFSEILDRVGSMGHFQFLHVAILGLPILNMANHNLLQIFTAATPVHHCR...unknowninhibitor
Solute carrier organic anion transporter family member 2B1MGPRIGPAGEVPQVPDKETKATMGTENTPGGKASPDPQDVRPSVFHNIKL...unknowninhibitor
Solute carrier organic anion transporter family member 1B3MDQHQHLNKTAESASSEKKKTRRCNGFKMFLAALSFSYIAKALGGIIMKI...unknowninhibitor
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference